Capri Holdings Ltd vs Regeneron Pharmaceuticals Inc — how do they compare? Capri Holdings Ltd trades at $15.62 (market cap $1.75B), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 46.9× Capri Holdings Ltd's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while Capri Holdings Ltd pays none. Which is the better fit depends on your goals.
| CPRI | REGN | |
|---|---|---|
Market Cap | $1.75B | $82.06B |
Sector | Consumer Staples | Health |
52-Week High | $27.66 | $812.27 |
52-Week Low | $14.98 | $555.51 |
Enterprise Value | $3.03B | $76.77B |
Dividend Yield | — | 0.47% |
Trailing returns across standard periods
Michael Kors, Versace, and Jimmy Choo are the brands of Capri Holdings, a marketer, distributor, and retailer of upscale accessories and apparel. Kors, Capri's largest brand, offers handbags, footwear, and apparel through more than 800 company-owned stores, wholesale, and e-commerce. Versace (acquired in 2018) is known for its ready-to-wear luxury fashion, while Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. John Idol has served as CEO since 2003.
Read more on CPRI →Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →